Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7058702 | 8086747 | F | 7058702-7 | 20100915 | 20101020 | 20101022 | EXP | GB-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2010-UK-00978UK | B.I. PHARMACEUTICALS,INC./RIDGEFIELD | 47 | YR | F | Y | 20101022 | PH |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7058702 | 1014954572 | PS | CATAPRES | 1 | ORAL | 0.3 MG | 920024 | 017407 | |||
| 7058702 | 1014954574 | C | OMEPRAZOLE | 1 | ORAL | 20 MG | |||||
| 7058702 | 1014954579 | C | NOSTHESTERONE | 2 | ORAL | 15 MG | |||||
| 7058702 | 1014954578 | C | CO-DYD | 2 | ORAL | 2 G | |||||
| 7058702 | 1014954575 | C | DIAZEPAM | 1 | ORAL | 6 MG | |||||
| 7058702 | 1014954577 | C | BEZAFIBRATE | 2 | ORAL | 400 MG | |||||
| 7058702 | 1014954573 | C | CHOLESTEROL TABLETS | 2 | |||||||
| 7058702 | 1014954576 | C | EZETIMIBE | 1 | ORAL | 10 MG |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 7058702 | 1014954572 | PRODUCT USED FOR UNKNOWN INDICATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 7058702 | LT |
| 7058702 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 7058702 | MYOCARDIAL INFARCTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 7058702 | 1014954572 | 20100915 | 20100915 |